Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward?

Warnes, H, Helliwell, R, Pearson, SM et al. (1 more author) (2018) Metabolic Control in Type 1 Diabetes: Is Adjunctive Therapy the Way Forward? Diabetes Therapy, 9 (5). pp. 1831-1851. ISSN 1869-6953

Abstract

Metadata

Authors/Creators:
  • Warnes, H
  • Helliwell, R
  • Pearson, SM
  • Ajjan, RA
Copyright, Publisher and Additional Information: © The Author(s), 2018. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/ by-nc/4.0/).
Keywords: DPP-4 inhibitors; GLP-1 analogues; Hypoglycaemia agents; Metformin; Pramlintide; SGLT2 inhibitors; Type 1 diabetes (T1DM)
Dates:
  • Published: October 2018
  • Published (online): 12 September 2018
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Clinical & Population Science Dept (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 31 May 2019 11:16
Last Modified: 31 May 2019 11:16
Status: Published
Publisher: Springer Healthcare
Identification Number: https://doi.org/10.1007/s13300-018-0496-z
Related URLs:

Share / Export

Statistics